Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk

We describe the institutional guidelines of a major tertiary cancer center with regard to using hypofractionated radiation regimens to treat glioblastoma as a measure to minimize exposure to coronavirus disease 2019 (COVID-19) while not sacrificing clinical outcomes. Our guidelines review level one...

Descripción completa

Detalles Bibliográficos
Autores principales: Noticewala, Sonal S., Ludmir, Ethan B., Bishop, Andrew J., Chung, Caroline, Ghia, Amol J., Grosshans, David, McGovern, Susan, Paulino, Arnold de la Cruz, Wang, Chenyang, Woodhouse, Kristina D., Yeboa, Debra N., Prabhu, Sujit S., Weathers, Shiao-Pei, Das, Prajnan, Koong, Albert C., McAleer, Mary Frances, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Practical considerations during COVID19 – Outcomes, education, and intervention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251361/
https://www.ncbi.nlm.nih.gov/pubmed/32775785
http://dx.doi.org/10.1016/j.adro.2020.04.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251361/
https://www.ncbi.nlm.nih.gov/pubmed/32775785
http://dx.doi.org/10.1016/j.adro.2020.04.040

Ejemplares similares